| Monday, September 28th 2020

Registration open for TreatER webcast seminar – World’s 1st CDNF clinical trial: Aiming for a breakthrough in Parkinson’s

Twitter
| Wednesday, September 16th 2020

Recording on CDNF webinar available: CDNF Phase I-II Study Met Primary Endpoints of Safety and Tolerability at 12 months

Twitter
| Thursday, August 27th 2020

Renishaw announces completion of clinical trial extension study, using its innovative drug delivery system in the investigation of CDNF as a treatment for Parkinson’s disease

Twitter
| Monday, July 27th 2020

TreatER webcast seminar – World’s 1st CDNF clinical trial: Aiming for a breakthrough in Parkinson’s

Twitter
| Tuesday, April 14th 2020

Parkinsonsawarenessweek marked by an article on our clinical study with CDNF, aiming at breakthrough in Parkinsons

Twitter
| Tuesday, March 10th 2020

Interview of Herantis Pharma CEO on Q4 2019 by Direkt Studios

Youtube
| Friday, February 28th 2020

CDNF phase I-II clinical study webinar: Topline data of the 6-month treatment period

Youtube
| Wednesday, February 26th 2020

Renishaw announces completion of the main part of a multi-centre clinical trial

Twitter
| Tuesday, February 25th 2020

Herantis Pharma Plc announces topline results of Phase 1-2 CDNF trial

Twitter
| Saturday, January 4th 2020

Patient Treatment Completed in Phase 1/2 Trial Testing Therapy Candidate CDNF in Parkinson’s Disease

Parkinson's News Today